Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Human Pluripotent Stem Cell-Derived Multipotent Vascular Progenitors of the Mesothelium Lineage Have Utility in Tissue Engineering and Repair.

Colunga T, Hayworth M, Kreß S, Reynolds DM, Chen L, Nazor KL, Baur J, Singh AM, Loring JF, Metzger M, Dalton S.

Cell Rep. 2019 Mar 5;26(10):2566-2579.e10. doi: 10.1016/j.celrep.2019.02.016.

2.

Comparative Analysis of 37 Acinetobacter Bacteriophages.

Turner D, Ackermann HW, Kropinski AM, Lavigne R, Sutton JM, Reynolds DM.

Viruses. 2017 Dec 24;10(1). pii: E5. doi: 10.3390/v10010005.

3.

Visualization of Phage Genomic Data: Comparative Genomics and Publication-Quality Diagrams.

Turner D, Sutton JM, Reynolds DM, Sim EM, Petty NK.

Methods Mol Biol. 2018;1681:239-260. doi: 10.1007/978-1-4939-7343-9_18.

PMID:
29134600
4.

The in situ bacterial production of fluorescent organic matter; an investigation at a species level.

Fox BG, Thorn RMS, Anesio AM, Reynolds DM.

Water Res. 2017 Nov 15;125:350-359. doi: 10.1016/j.watres.2017.08.040. Epub 2017 Aug 18.

5.
6.

In vitro discrimination of wound-associated bacteria by volatile compound profiling using selected ion flow tube-mass spectrometry.

Slade EA, Thorn RMS, Lovering AM, Young A, Reynolds DM.

J Appl Microbiol. 2017 Jul;123(1):233-245. doi: 10.1111/jam.13473.

PMID:
28423217
7.

Characterisation and genome sequence of the lytic Acinetobacter baumannii bacteriophage vB_AbaS_Loki.

Turner D, Wand ME, Briers Y, Lavigne R, Sutton JM, Reynolds DM.

PLoS One. 2017 Feb 16;12(2):e0172303. doi: 10.1371/journal.pone.0172303. eCollection 2017.

8.

Genome Sequence of vB_AbaS_TRS1, a Viable Prophage Isolated from Acinetobacter baumannii Strain A118.

Turner D, Wand ME, Sutton JM, Centron D, Kropinski AM, Reynolds DM.

Genome Announc. 2016 Oct 13;4(5). pii: e01051-16. doi: 10.1128/genomeA.01051-16.

9.

Whole-Genome Sequencing and iPLEX MassARRAY Genotyping Map an EMS-Induced Mutation Affecting Cell Competition in Drosophila melanogaster.

Lee CH, Rimesso G, Reynolds DM, Cai J, Baker NE.

G3 (Bethesda). 2016 Oct 13;6(10):3207-3217. doi: 10.1534/g3.116.029421.

10.

Amnion as a surrogate tissue reporter of the effects of maternal preeclampsia on the fetus.

Suzuki M, Maekawa R, Patterson NE, Reynolds DM, Calder BR, Reznik SE, Heo HJ, Einstein FH, Greally JM.

Clin Epigenetics. 2016 Jun 10;8:67. doi: 10.1186/s13148-016-0234-1. eCollection 2016.

11.

Fluorescence spectroscopy for wastewater monitoring: A review.

Carstea EM, Bridgeman J, Baker A, Reynolds DM.

Water Res. 2016 May 15;95:205-19. doi: 10.1016/j.watres.2016.03.021. Epub 2016 Mar 10. Review.

PMID:
26999254
12.

A proposed new bacteriophage subfamily: "Jerseyvirinae".

Anany H, Switt AI, De Lappe N, Ackermann HW, Reynolds DM, Kropinski AM, Wiedmann M, Griffiths MW, Tremblay D, Moineau S, Nash JH, Turner D.

Arch Virol. 2015 Apr;160(4):1021-33. doi: 10.1007/s00705-015-2344-z. Epub 2015 Feb 8.

PMID:
25663216
13.

Characterisation of dissolved organic matter fluorescence properties by PARAFAC analysis and thermal quenching.

Carstea EM, Baker A, Bieroza M, Reynolds DM, Bridgeman J.

Water Res. 2014 Sep 15;61:152-61. doi: 10.1016/j.watres.2014.05.013. Epub 2014 May 21.

PMID:
24908578
14.

Mosaic epigenetic dysregulation of ectodermal cells in autism spectrum disorder.

Berko ER, Suzuki M, Beren F, Lemetre C, Alaimo CM, Calder RB, Ballaban-Gil K, Gounder B, Kampf K, Kirschen J, Maqbool SB, Momin Z, Reynolds DM, Russo N, Shulman L, Stasiek E, Tozour J, Valicenti-McDermott M, Wang S, Abrahams BS, Hargitai J, Inbar D, Zhang Z, Buxbaum JD, Molholm S, Foxe JJ, Marion RW, Auton A, Greally JM.

PLoS Genet. 2014 May 29;10(5):e1004402. doi: 10.1371/journal.pgen.1004402. eCollection 2014.

15.

Comparative antimicrobial activities of aerosolized sodium hypochlorite, chlorine dioxide, and electrochemically activated solutions evaluated using a novel standardized assay.

Thorn RM, Robinson GM, Reynolds DM.

Antimicrob Agents Chemother. 2013 May;57(5):2216-25. doi: 10.1128/AAC.02589-12. Epub 2013 Mar 4.

16.

Application of bacterial bioluminescence to assess the efficacy of fast-acting biocides.

Robinson GM, Tonks KM, Thorn RM, Reynolds DM.

Antimicrob Agents Chemother. 2011 Nov;55(11):5214-20. doi: 10.1128/AAC.00489-11. Epub 2011 Aug 29.

17.

Electrochemically activated solutions: evidence for antimicrobial efficacy and applications in healthcare environments.

Thorn RM, Lee SW, Robinson GM, Greenman J, Reynolds DM.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):641-53. doi: 10.1007/s10096-011-1369-9. Epub 2011 Aug 2. Review.

PMID:
21809085
18.

Production of antibiotic substances by actinomycetes.

Waksman SA, Schatz A, Reynolds DM.

Ann N Y Acad Sci. 2010 Dec;1213:112-24. doi: 10.1111/j.1749-6632.2010.05861.x. No abstract available.

PMID:
21175680
19.

Multivariate analysis of bacterial volatile compound profiles for discrimination between selected species and strains in vitro.

Thorn RM, Reynolds DM, Greenman J.

J Microbiol Methods. 2011 Feb;84(2):258-64. doi: 10.1016/j.mimet.2010.12.001. Epub 2010 Dec 16.

PMID:
21167880
20.

Evaluation of the efficacy of electrochemically activated solutions against nosocomial pathogens and bacterial endospores.

Robinson GM, Lee SW, Greenman J, Salisbury VC, Reynolds DM.

Lett Appl Microbiol. 2010 Mar;50(3):289-94. doi: 10.1111/j.1472-765X.2009.02790.x. Epub 2009 Dec 16.

21.

Monte carlo model of stricture formation in photodynamic therapy of normal pig esophagus.

Jones LR, Preyer NW, Wolfsen HC, Reynolds DM, Davis MA, Wallace MB.

Photochem Photobiol. 2009 Jan-Feb;85(1):341-6. doi: 10.1111/j.1751-1097.2008.00445.x.

PMID:
19161398
22.

Can fluorescence spectrometry be used as a surrogate for the Biochemical Oxygen Demand (BOD) test in water quality assessment? An example from South West England.

Hudson N, Baker A, Ward D, Reynolds DM, Brunsdon C, Carliell-Marquet C, Browning S.

Sci Total Environ. 2008 Feb 25;391(1):149-58. Epub 2007 Dec 4.

PMID:
18054993
23.

Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed.

McLean AB, D'Amour KA, Jones KL, Krishnamoorthy M, Kulik MJ, Reynolds DM, Sheppard AM, Liu H, Xu Y, Baetge EE, Dalton S.

Stem Cells. 2007 Jan;25(1):29-38.

24.

The rapid detection of methyl tert-butyl ether (MtBE) in water using a prototype gas sensor system.

de Lacy Costello BP, Sivanand PS, Ratcliffe NM, Reynolds DM.

Water Sci Technol. 2005;52(8):117-23.

PMID:
16312958
25.
26.

Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1.

Reynolds DM, Falk CT, Li A, King BF, Kamath PS, Huston J 3rd, Shub C, Iglesias DM, Martin RS, Pirson Y, Torres VE, Somlo S.

Am J Hum Genet. 2000 Dec;67(6):1598-604. Epub 2000 Oct 23.

27.

Forkhead transcription factors, Fkh1p and Fkh2p, collaborate with Mcm1p to control transcription required for M-phase.

Kumar R, Reynolds DM, Shevchenko A, Shevchenko A, Goldstone SD, Dalton S.

Curr Biol. 2000 Jul 27-Aug 10;10(15):896-906.

28.

Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease.

Reynolds DM, Hayashi T, Cai Y, Veldhuisen B, Watnick TJ, Lens XM, Mochizuki T, Qian F, Maeda Y, Li L, Fossdal R, Coto E, Wu G, Breuning MH, Germino GG, Peters DJ, Somlo S.

J Am Soc Nephrol. 1999 Nov;10(11):2342-51.

29.

Identification of PKD2L, a human PKD2-related gene: tissue-specific expression and mapping to chromosome 10q25.

Wu G, Hayashi T, Park JH, Dixit M, Reynolds DM, Li L, Maeda Y, Cai Y, Coca-Prados M, Somlo S.

Genomics. 1998 Dec 15;54(3):564-8.

PMID:
9878261
30.

Somatic inactivation of Pkd2 results in polycystic kidney disease.

Wu G, D'Agati V, Cai Y, Markowitz G, Park JH, Reynolds DM, Maeda Y, Le TC, Hou H Jr, Kucherlapati R, Edelmann W, Somlo S.

Cell. 1998 Apr 17;93(2):177-88.

31.

Evaluation of helical computed tomography scan parameters for vascular imaging.

Reynolds DM, Hazle JD, Johnston DA, Charnsangavej C.

Med Phys. 1998 Feb;25(2):176-82.

PMID:
9507477
32.

Novel stop and frameshifting mutations in the autosomal dominant polycystic kidney disease 2 (PKD2) gene.

Viribay M, Hayashi T, Tellería D, Mochizuki T, Reynolds DM, Alonso R, Lens XM, Moreno F, Harris PC, Somlo S, San Millán JL.

Hum Genet. 1997 Dec;101(2):229-34.

PMID:
9402976
33.

Molecular cloning, cDNA sequence analysis, and chromosomal localization of mouse Pkd2.

Wu G, Mochizuki T, Le TC, Cai Y, Hayashi T, Reynolds DM, Somlo S.

Genomics. 1997 Oct 1;45(1):220-3.

PMID:
9339380
34.

A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2).

Veldhuisen B, Saris JJ, de Haij S, Hayashi T, Reynolds DM, Mochizuki T, Elles R, Fossdal R, Bogdanova N, van Dijk MA, Coto E, Ravine D, Nørby S, Verellen-Dumoulin C, Breuning MH, Somlo S, Peters DJ.

Am J Hum Genet. 1997 Sep;61(3):547-55.

35.

Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2).

Hayashi T, Mochizuki T, Reynolds DM, Wu G, Cai Y, Somlo S.

Genomics. 1997 Aug 15;44(1):131-6.

PMID:
9286709
36.

PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein.

Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S.

Science. 1996 May 31;272(5266):1339-42.

PMID:
8650545
37.

Evidence for a third genetic locus for autosomal dominant polycystic kidney disease.

Daoust MC, Reynolds DM, Bichet DG, Somlo S.

Genomics. 1995 Feb 10;25(3):733-6.

PMID:
7759112
38.

Conditions affecting the mutagenicity of trichloroethylene in Salmonella.

McGregor DB, Reynolds DM, Zeiger E.

Environ Mol Mutagen. 1989;13(3):197-202.

PMID:
2651116
39.

6- and 8-hydroxy-3,4-dihydro-3-(dipropylamino)-2H-1-benzopyrans. Dopamine agonists with autoreceptor selectivity.

Wise LD, DeWald HA, Hawkins ES, Reynolds DM, Heffner TG, Meltzer LT, Pugsley TA.

J Med Chem. 1988 Mar;31(3):688-91.

PMID:
3346882
40.

Sensitivity and specificity of the Neuropsychological Impairment Scale (NIS).

O'Donnell WE, De Soto CB, Reynolds DM.

J Clin Psychol. 1984 Mar;40(2):553-5.

PMID:
6725579
41.

Validity and reliability of the Neuropsychological Impairment Scale (NIS).

O'Donnell WE, Reynolds DM, De Soto CB.

J Clin Psychol. 1984 Mar;40(2):549-53.

PMID:
6725578
42.

A cognitive deficit subscale of the SCL-90-R.

O'Donnell WE, DeSoto CB, Reynolds DM.

J Clin Psychol. 1984 Jan;40(1):241-6.

PMID:
6746937
44.

Physiological and ultrastructural characterization of a new acidophilic Thiobacillus species (T. kabobis).

Reynolds DM, Laishley EJ, Costerton JW.

Can J Microbiol. 1981 Feb;27(2):151-61.

PMID:
7214235
45.
46.

Medication delivery time requirements in centralized and decentralized unit dose drug distribution systems.

Reynolds DM, Johnson MH, Longe RL.

Am J Hosp Pharm. 1978 Aug;35(8):941-3.

PMID:
677142
47.

A developmental study of hemisphere specialization for alphabetical stimuli.

Reynolds DM, Jeeves MA.

Cortex. 1978 Jun;14(2):259-67.

PMID:
679707
48.
49.

Further studies of crossed and uncrossed pathway responding in callosal agenesis--reply to Kinsbourne and Fisher.

Reynolds DM, Jeeves MA.

Neuropsychologia. 1974 Mar;12(2):287-90. No abstract available.

PMID:
4842918
50.

Recovery of memory functioning in alcoholics following prolonged alcohol intoxication.

Allen RP, Faillace LA, Reynolds DM.

J Nerv Ment Dis. 1971 Dec;153(6):417-23. No abstract available.

PMID:
5123712

Supplemental Content

Loading ...
Support Center